Topical Concurrent Session 2A – From nociceptive pathways to analgesic drug discovery


APSNZPS 2018: Topical Concurrent Session 2A

SKU: 22-APSNZPS2018 Category:


Topical Concurrent Session 2A: From nociceptive pathways to analgesic drug discovery
Chair: Dr Gila Moalem-Taylor, University of NSW, NSW

Over the past decade, there has been an increased understanding of nociceptive pathways and the pathophysiological mechanisms underlying pathological pain, and new experimental treatments for pain relief have emerged. This topical session will provide insight into novel techniques in pain research, and will provide information about novel targets and their potential to treat chronic pain. Topics will be addressed by leading scientists in this field; Professor Stephen McMahon will present a novel optical imaging technique to assess large networks of sensory neurons and their functional responses to peripheral stimulation. Professor Macdonald Christie will address development of peptide toxins from venomous invertebrates as potential therapeutics for chronic pain management, and Professor Maree Smith will focus on preclinical investigations of the role of angiotensin II signalling via the angiotensin II type 2 receptor in the pathobiology of peripheral neuropathic pain.

The session would be of interest to researchers, health professionals and students with interest in basic pain mechanisms, novel techniques, and analgesic drug discovery.

Professor Stephen McMahon, King’s College London, UK
Professor Macdonald Christie. University of Sydney, NSW
Professor Maree Smith, University of Queensland, QLD

Additional information